HEALTHCARE SERVICES GROUP INC (HCSG) stock intrinsic value fair value estimate & owner earnings analysis

Healthcare Services Group runs the housekeeping and laundry (Environmental Services) and food service (Dietary) departments inside nursing homes and other senior-care facilities, under service contracts. It needs almost no equipment (about $6 million of capital spending a year against $1.84 billion of 2025 revenue), has no borrowings (a $300 million credit line is undrawn and runs to late 2027), and held $123 million of cash plus $41 million of unrestricted securities at June 30, 2026. The service itself is steady. The risk is the customer: nursing-home operators are often thinly capitalized, and the company has repeatedly had to write off what they owe. Its charge for uncollectible accounts was $10.5 million in 2021, $32.0 million in 2022, $35.6 million in 2023, $46.8 million in 2024 and $83.1 million in 2025. The 2025 figure includes $63.9 million for Genesis Healthcare, which filed for Chapter 11 on July 9, 2025; Genesis was 10.9% of 2023 revenue and 7.3% ($133.5 million) of 2025 revenue, still a customer, and the $50.4 million of invoices and $20.4 million of notes it owed are fully reserved. Total reserves were $147.0 million at the end of 2025 and about $150 million at June 30, 2026. How we measure earnings. We look at the cash the business produces for shareholders after share-based pay and the equipment needed to stay in business. Swings in what customers owe are removed, but the bad-debt charge stays in as a real cost, so a customer failure reduces earnings in the year it is recognized. Only maintenance equipment spending is deducted; growth spending is tiny. On that basis cash earnings per share were $1.15 (2016), $1.28 (2017), $1.03 (2018), $1.00 (2019), $1.42 (2020, an outlier pandemic year and the highest of the ten), $0.87 (2021), $0.68 (2022), $0.60 (2023), $0.64 (2024) and $0.88 (2025). 2025 as reported was $1.26, but that includes about $37 million (roughly $28 million after tax) of one-time pandemic-era federal Employee Retention Credit refunds net of fees, which we removed; $12.3 million of further refunds is held as a liability and not counted. Our reference level is the middle value of 2018 through 2025, leaving out 2020: about $65.9 million a year before interest on past borrowings, with individual years ranging from $52 million (2023) to $80 million (2018). That window spans a normal stretch and two heavy customer-failure stretches, 2018 and 2022 to 2025. One item we could not fully reconcile: 2025 carried a $19.2 million non-cash tax deferral alongside a $30.6 million reduction in taxes payable; because we rely on a multi-year middle value, it does not move our figures much. What has changed since our previous analysis. The first half of 2026 was strong: net income of $48.8 million (against a $15.1 million loss in the first half of 2025), on revenue of $933.6 million, up 3.0%. The bad-debt charge was only $3.6 million, versus $57.5 million a year earlier. Our previous figures were built on a different basis and are not directly comparable. The last four quarters ran well above the reference level even after removing the tax-credit income and replacing the unusually small first-half 2026 bad-debt charge with a normal one (about $37 million a year, matching the $36.8 million and $37.7 million actually written off in 2025 and 2024); on that footing they annualize to roughly $80 million or more. That level has not yet been tested by another customer failure, so we credit part of it. We tested whether a low bad-debt charge is believable: at the end of 2025 the reserve beyond Genesis was $76 million, about two years of normal write-offs, so a quiet stretch is plausible. Base case. Business cash earnings of $72 million a year, flat for ten years and beyond. Cash earnings per share rose 38% from 2024 to 2025 (excluding the tax credits, $0.64 to $0.88); for year one we assume 0% growth, so no explanation of a reversal is needed. The step from the $65.9 million reference level to $72 million is the partial credit for the last four quarters, not growth. We credit no growth even though revenue rose 2.7% in 2024, 7.1% in 2025 and 3.0% in the first half of 2026, because we cannot point to contracted or repeatable earnings growth: cash earnings per share have not risen over the decade. What keeps the earnings going is the structure of the business: outsourced department services in senior-care facilities, with revenue between $1.56 billion and $2.0 billion in every year from 2016 to 2025. The business is worth $1.20 billion; it owes nothing; surplus cash of about $80 million (cash and unrestricted securities of $165 million, less roughly $70 million needed to run payroll and $12 million of refunds held as a liability) brings the total to $1.28 billion, or $18.31 per share on 69.9 million diluted shares. Bear case. We use the pandemic-era episode: from 2019 ($78.4 million) to the 2022 to 2024 average ($53.0 million), business cash earnings fell about one third. Applied to $72 million that is $48.6 million, less about $5 million a year for the loss of Genesis (about 5% pre-bad-debt margin on $133.5 million of revenue, after tax), because a Chapter 11 debtor can reject or sell off contracts. We then add two more Genesis-sized failures, in years 2 and 7, each costing about $48 million after tax ($63.9 million less tax). Earnings are $43.6 million in years 1 and 3, minus $4.4 million in year 2, then $48 million a year, with year 7 at zero, and $48 million thereafter. The business is worth $714 million, owes nothing, and with $80 million of surplus cash is worth $794 million, or $11.35 per share. Even the worst year (year 2) is covered by cash on hand. Bull case. The last four quarters' level proves durable: $95 million a year, growing 2% a year for five years (revenue's actual pace over the decade was about 1.8% a year), reaching $104.9 million and then flat. The business is worth $1.73 billion; it owes nothing; with $80 million of surplus cash the total is $1.81 billion, or $25.90 per share. How we arrived at the margin-of-safety price. We are moderately, not highly, sure of the earnings level: the history says $52 to $80 million, the last four quarters say more, and only part of that is credited. The worst plausible outcome is another operator failure like Genesis in the same stretch as a pandemic-style drop in occupancy; each failure costs about $48 million after tax (about $0.69 per share). Outcomes not modeled include an IRS challenge to the Employee Retention Credit refunds and a further slide in customers' finances; the company's structure would survive them: no debt, $165 million of cash and securities, and roughly $6 million a year of equipment spending. If we are wrong about the level and it is really the $53 million of 2022 to 2024, the shares would be worth about $13.80; if we are wrong about credit losses and they run at the 2024-2025 pace, we are in the bear case at about $11. The price assumes a holding period of up to five years. The company pays no dividend but returns cash through buybacks: $61.6 million for 4.0 million shares in 2025 and $44.9 million in the first half of 2026, taking diluted shares from 73.0 million (2025) to 69.9 million (second quarter 2026). The margin-of-safety price is $9.00. At that price the whole business is valued at about $549 million net of the surplus cash, against roughly $66 million a year of cash earnings through the last cycle (a yield of 12%) and $48 million in our bear case (8.7%), with buybacks compounding the per-share result; that implied return in the bear case, and a much higher one in the base case, is what supports $9.00.